Latest News

Levi Garraway, MD, PhD  (Credit: LinkedIn)
Genentech Reports High-Dose Ocrelizumab Fails to Show Additional Benefit in Relapsing MS

April 2nd 2025

The company's phase 3 MUSETTE trial reported that an increased ocrelizumab dose did not further slow disability progression but reinforced the efficacy of the approved 600 mg dose.

Iris Bosch, MS  (Credit: LinkedIn)
Remote Screening for Early Alzheimer’s Holds Promise Amid Key Challenges

April 2nd 2025

Alzheimer Biomarkers pTau217 and pTau181 Show High Group-Level Correlation With Trial End Points
Alzheimer Biomarkers pTau217 and pTau181 Show High Group-Level Correlation With Trial End Points

April 2nd 2025

NeuroVoices: Cynthia Lemere, PhD, on Exploring the Role of Complement in ARIA and CAA
NeuroVoices: Cynthia Lemere, PhD, on Exploring the Role of Complement in ARIA and CAA

April 2nd 2025

Joan Groeneveld  (Credit: LinkedIn)
Genetic Risk Factors Influence Age at Onset in Autosomal Dominant Alzheimer Disease

April 1st 2025

Coverage of the 2025 MDA Clinical & Scientific Conference

Get direct access to interviews with experts, as well as the latest data and clinical news updates, straight from the conference floor in Dallas, Texas.

MDA 2025

Conference Coverage

View All
Iris Bosch, MS  (Credit: LinkedIn)
Remote Screening for Early Alzheimer’s Holds Promise Amid Key Challenges

April 2nd 2025

Alzheimer Biomarkers pTau217 and pTau181 Show High Group-Level Correlation With Trial End Points
Alzheimer Biomarkers pTau217 and pTau181 Show High Group-Level Correlation With Trial End Points

April 2nd 2025

Overviewing Design and Topline Data From Phase 3 APOLLOE4 Study of Valiltramiprosate in Alzheimer Disease: Anton Porsteinsson, MD
Overviewing Design and Topline Data From Phase 3 APOLLOE4 Study of Valiltramiprosate in Alzheimer Disease: Anton Porsteinsson, MD

April 2nd 2025

NeuroVoices: Cynthia Lemere, PhD, on Exploring the Role of Complement in ARIA and CAA
NeuroVoices: Cynthia Lemere, PhD, on Exploring the Role of Complement in ARIA and CAA

April 2nd 2025

Video Interviews

Most Recent

© 2025 MJH Life Sciences

All rights reserved.